Can we estimate the 'social' value of a QALY? Four core issues to resolve.

[1]  Richard M. Smith,et al.  Citizen, consumer or both? Reconceptualising demand in health care , 2017 .

[2]  Richard D. Smith.  Construction of the contingent valuation market in health care: a critical assessment. , 2003, Health economics.

[3]  N. Devlin,et al.  Cost-effectiveness Thresholds: Economic and Ethical Issues , 2002 .

[4]  James K. Hammitt,et al.  QALYs Versus WTP , 2002 .

[5]  P. Dolan,et al.  Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis? , 2002, Journal of health economics.

[6]  R. Smith.  The relative sensitivity of willingness-to-pay and time-trade-off to changes in health status: an empirical investigation. , 2001, Health economics.

[7]  Michael E. Chernew,et al.  Willingness to Pay for a Quality-adjusted Life Year , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[8]  S. Cunningham,et al.  Relationship between utility values and willingness to pay in patients undergoing orthognathic treatment. , 2000, Community dental health.

[9]  J. Quiggin,et al.  Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis? , 1999, Journal of health economics.

[10]  E. Nord.  Cost-Value Analysis in Health Care: Making Sense out of QALYS , 1999 .

[11]  T Klose,et al.  The contingent valuation method in health care. , 1999, Health policy.

[12]  B. O'brien,et al.  Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years. , 1998, Journal of clinical epidemiology.

[13]  A Gafni,et al.  Health care contingent valuation studies: a review and classification of the literature. , 1998, Health economics.

[14]  M. Johannesson,et al.  Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[15]  A. Garber,et al.  Economic foundations of cost-effectiveness analysis. , 1997, Journal of health economics.

[16]  M. Johannesson.  The relationship between cost-effectiveness analysis and cost-benefit analysis. , 1995, Social science & medicine.

[17]  C E Phelps,et al.  On the (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analyses , 1991, International Journal of Technology Assessment in Health Care.

[18]  A. Culyer.  THE NORMATIVE ECONOMICS OF HEALTH CARE FINANCE AND PROVISION , 1989 .

[19]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[20]  G. Torrance.  Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[21]  John D. Arras,et al.  Ethical Issues in Modern Medicine , 1977 .

[22]  J. D. Graaff,et al.  Theoretical welfare economics , 1957 .

[23]  I. Little.  A critique of welfare economics , 1951 .

[24]  Nick Hanley,et al.  Estimating the monetary value of health care: lessons from environmental economics. , 2003, Health economics.

[25]  Graham Loomes,et al.  Valuing Life Years and QALYs: Transferability and Convertability of Values Across the UK Public Sector , 2002 .

[26]  Alan D. Lopez,et al.  Summary Measures of Population Health: Concepts, Ethics, Measurement and Applications , 2002 .

[27]  I. Bateman.  Economic valuation with stated preference techniques : a manual : department for transport , 2002 .

[28]  J. Olsen,et al.  Theory versus practice: a review of 'willingness-to-pay' in health and health care. , 2001, Health economics.

[29]  A. Mcguire,et al.  Providing health care : the economics of alternative systems of finance and delivery , 1991 .